Tetrahydroaminoacridine (THA) in Alzheimer's disease.
- 1 April 1989
- Vol. 298 (6677) , 845-846
- https://doi.org/10.1136/bmj.298.6677.845
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- CHOLINERGIC SIDE-EFFECTS OF TETRAHYDROAMINOACRIDINEThe Lancet, 1988
- HEPATOTOXICITY OF TETRAHYDROACRIDINEThe Lancet, 1988
- Oral Tetrahydroaminoacridine in the Treatment of Senile Dementia, Alzheimer's TypeNew England Journal of Medicine, 1987
- Critical review of clinical trials in senile dementia--IIPublished by Oxford University Press (OUP) ,1987
- TREATMENTS FOR ALZHEIMER PATIENTS???ABOVE ALL DO NO HARMAlzheimer Disease & Associated Disorders, 1987
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- The aminopyridinesGeneral Pharmacology: The Vascular System, 1982
- Cholinomimetic Treatment Fails to Improve Memory DisordersNew England Journal of Medicine, 1980
- Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.BMJ, 1978
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976